期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Narciclasine,a novel topoisomerase I inhibitor,exhibited potent anti-cancer activity against cancer cells
1
作者 Meichen Wang Leilei Liang +9 位作者 Rong Wang Shutao Jia Chang Xu Yuting Wang Min Luo Qiqi Lin Min Yang Hongyu Zhou Dandan Liu Chen Qing 《Natural Products and Bioprospecting》 CSCD 2023年第1期482-492,共11页
DNA topoisomerases are essential nuclear enzymes in correcting topological DNA errors and maintaining DNA integrity.Topoisomerase inhibitors are a significant class of cancer chemotherapeutics with a definite curative... DNA topoisomerases are essential nuclear enzymes in correcting topological DNA errors and maintaining DNA integrity.Topoisomerase inhibitors are a significant class of cancer chemotherapeutics with a definite curative effect.Natural products are a rich source of lead compounds for drug discovery,including anti-tumor drugs.In this study,we found that narciclasine(NCS),an amaryllidaceae alkaloid,is a novel inhibitor of topoisomerase I(topo I).Our data demonstrated that NCS inhibited topo I activity and reversed its unwinding effect on p-HOT DNA substrate.However,it had no obvious effect on topo II activity.The molecular mechanism of NCS inhibited topo I showed that NCS did not stabilize topo-DNA covalent complexes in cells,indicating that NCS is not a topo I poison.A blind docking result showed that NCS could bind to topo I,suggesting that NCS might be a topo I suppressor.Additionally,NCS exhibited a potent anti-proliferation effect in various cancer cells.NCS arrested the cell cycle at G_(2)/M phase and induced cell apoptosis.Our study reveals the antitumor mechanisms of NCS and provides a good foundation for the development of anti-cancer drugs based on topo I inhibition. 展开更多
关键词 topoISOMERASE Narciclasine(NCS) topo i-dna covalent complex DNA damage Cell cycle Apoptosis
暂未订购
新型喜树碱类抗癌药物的研究进展 被引量:9
2
作者 刘丹 张龙 +3 位作者 达飞 尚沛津 张娟 姚琳 《现代生物医学进展》 CAS 2016年第5期990-992,共3页
喜树碱是1966年由喜树中分离而来的一种五环结构的生物碱,早期对其抗肿瘤活性的发现更是引发了科学家们对此类化合物极大的研究兴趣,现在已经证实喜树碱类化合物主要是通过抑制在DNA代谢过程中发挥重要作用的I型拓扑异构酶。但其自身因... 喜树碱是1966年由喜树中分离而来的一种五环结构的生物碱,早期对其抗肿瘤活性的发现更是引发了科学家们对此类化合物极大的研究兴趣,现在已经证实喜树碱类化合物主要是通过抑制在DNA代谢过程中发挥重要作用的I型拓扑异构酶。但其自身因水溶性差、毒副作用强,在临床应用上易出现不良反应。半个世纪以来,国内外研究者在对其作用机制及构效关系的研究基础上,开发出了数以百计的喜树碱类衍生物,很多已经进入临床或临床前研究。但目前仅有两种喜树碱类的化合物拓扑替康和依立替康被美国FDA批准应用于临床上肿瘤的治疗。本文就已上市的喜树碱类化合物以及喜树碱类抗肿瘤药物开发的挑战进行了综述。 展开更多
关键词 喜树碱 topo i-dna复合物 化学稳定性
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部